EVAX logo

Evaxion Biotech A/S

EVAX
Healthcare|Biotechnology|DK
$3.00
+0.24 (+8.70%)
DCF Value
$33.35
Tangible Book / Share
$22.86
Cash / Share
$33.57
Next Earnings Report
Nov 19, 2026
EPS est. -$0.01 · Revenue est. $300.0K
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Dec 10, 2025 (424B5). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

New phase 2 data highlight the strength of the immune response induced by personalized cancer vaccine EVX-01
Nov 6, 2026 · GlobeNewsWire
Evaxion will present new target validation data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia at ASH 2026 Meeting
Nov 4, 2026 · GlobeNewsWire
Evaxion to present broad biomarker data from phase 2 trial with personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting
Nov 3, 2026 · GlobeNewsWire
Evaxion receives International Prix Galien Award for AI-Immunology™ as best digital health solution
Oct 30, 2026 · GlobeNewsWire
Evaxion announces 89% vaccine target precision and sustained T-cell and clinical responses at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01
Oct 23, 2026 · GlobeNewsWire
Evaxion reports sustained clinical responses for all patients at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01
Oct 19, 2026 · GlobeNewsWire
Evaxion will present new immune data for personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting
Oct 2, 2026 · GlobeNewsWire
Evaxion applies its AI-Immunology™ platform in autoimmune diseases
Sep 14, 2026 · GlobeNewsWire
Evaxion announces business update and second quarter 2026 financial results
Aug 20, 2026 · GlobeNewsWire
Evaxion expands and refocuses R&D pipeline with EVX-05, an AI-designed off-the-shelf brain cancer vaccine program
Aug 17, 2026 · GlobeNewsWire

SEC Filings (119)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 6, 20266-KForeign issuer reportDocumentIndex
Nov 4, 20266-KForeign issuer reportDocumentIndex
Nov 4, 20266-KForeign issuer reportDocumentIndex
Nov 3, 20266-KForeign issuer reportDocumentIndex
Oct 30, 20266-KForeign issuer reportDocumentIndex
Oct 23, 20266-KForeign issuer reportDocumentIndex
Oct 19, 20266-KForeign issuer reportDocumentIndex
Oct 2, 20266-KForeign issuer reportDocumentIndex
Sep 14, 20266-KForeign issuer reportDocumentIndex
Sep 4, 20266-KForeign issuer reportDocumentIndex
Aug 20, 20266-KForeign issuer reportDocumentIndex
Aug 20, 20266-KForeign issuer reportDocumentIndex
Aug 17, 20266-KForeign issuer reportDocumentIndex
Aug 14, 20266-KForeign issuer reportDocumentIndex
Jul 17, 20266-KForeign issuer reportDocumentIndex
Jul 13, 20266-KForeign issuer reportDocumentIndex
Jul 1, 20266-KForeign issuer reportDocumentIndex
Jun 12, 20266-KForeign issuer reportDocumentIndex
Jun 11, 20266-KForeign issuer reportDocumentIndex
May 12, 20266-KForeign issuer reportDocumentIndex
May 7, 20266-KForeign issuer reportDocumentIndex
May 4, 20266-KForeign issuer reportDocumentIndex
Apr 27, 20266-KForeign issuer reportDocumentIndex
Apr 22, 20266-KForeign issuer reportDocumentIndex
Apr 17, 20266-KForeign issuer reportDocumentIndex
Apr 17, 20266-KForeign issuer reportDocumentIndex
Apr 16, 20266-KForeign issuer reportDocumentIndex
Apr 7, 20266-KForeign issuer reportDocumentIndex
Mar 30, 20266-KForeign issuer reportDocumentIndex
Mar 19, 20266-KForeign issuer reportDocumentIndex
Mar 19, 20266-KForeign issuer reportDocumentIndex
Mar 17, 20266-KForeign issuer reportDocumentIndex
Mar 5, 20266-KForeign issuer reportDocumentIndex
Mar 5, 202620-FAnnual report (foreign)DocumentIndex
Mar 5, 20266-KForeign issuer reportDocumentIndex
Mar 2, 20266-KForeign issuer reportDocumentIndex
Feb 27, 20266-KForeign issuer reportDocumentIndex
Jan 13, 20266-KForeign issuer reportDocumentIndex
Jan 7, 20266-KForeign issuer reportDocumentIndex
Dec 19, 20256-KForeign issuer reportDocumentIndex